JHU37152
JHU37152 is a potent and brain-penetrant DREADD agonist, with EC50s of 5 nM and 0.5 nM for hM3Dq and hM4Di DREADDs in HEK-293 cells, respectively. JHU37152 exhibits selective [3H]Clozapine displacement from DREADDs and not from other Clozapine-binding sites in mice brain tissue[1].
Product Specifications
CAS Number
[2369979-67-7]
UNSPSC
12352005
Target
MAChR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/jhu37152.html
Purity
99.45
Solubility
DMSO : 33.33 mg/mL (ultrasonic)
Smiles
FC1=C2C(NC3=CC=C(Cl)C=C3N=C2N4CCN(CC)CC4)=CC=C1
Molecular Formula
C19H20ClFN4
Molecular Weight
358.84
References & Citations
[1]Bonaventura J, et, al. High-potency ligands for DREADD imaging and activation in rodents and monkeys. Nat Commun. 2019 Oct 11;10 (1) :4627.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MAChR3; mAChR4
Available Sizes
Explore Other Products
Browse additional items from our catalog
Recombinant Mycobacterium Gilvum prcA Protein (aa 1-251)
Monoclonal RAPGEFL1 Antibody (monoclonal) (M04), Clone: 4G2
MGAT2, CT (Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, Mannoside Acetylglucosaminyltransferase 2, N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II, Beta-1,2-N-Acetylglucosaminyltransferase II, GlcNAc-T
MGAT2, CT (Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, Mannoside Acetylglucosaminyltransferase 2, N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II, Beta-1,2-N-Acetylglucosaminyltransferase II, GlcNAc-T